HexemBio
PrivateLast Round
Seed
Apr 7, 2026
Total Funding Raised
$10.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HexemBio operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in April 2026.
HexemBio is a biotechnology company that develops regenerative therapies for aging blood stem cells using its proprietary Synthetic Human Yolk Sac technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HexemBio Comparables
Compare HexemBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneAGE Bio | 84% | |
| ExCellThera | 80% | |
| Mogling Bio Inc. | 79% |
For institutional investors. Book with your work email.
HexemBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
HexemBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Seed |
| Venture Science | Seed |
| Gaingels | Seed, Pre Seed |
| Treeo VC | Seed |
| ZAKA VC | Seed |
| Innovation Works | Seed |
| E2MC Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 79% MoM.
- May 27, 2026
Grew 175% QoQ from 4 to 11 employees.
For institutional investors. Book with your work email.
HexemBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HexemBio's valuation, stock price, and market status.
Is HexemBio a public or private company?
HexemBio is a private company.
What is the current stock price of HexemBio?
HexemBio is a private company, so its shares have no public market price. Caplight tracks HexemBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HexemBio worth (valuation)?
Valuation information for HexemBio is not publicly available.
Can I buy HexemBio stock?
HexemBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HexemBio's last funding round?
HexemBio's most recent funding round was Seed on April 7, 2026.
Who are the main investors in HexemBio?
Key investors in HexemBio include Draper Associates.
Will HexemBio IPO soon?
No public IPO plans have been announced for HexemBio.
How can I track HexemBio secondary market activity?
Caplight tracks bids, offers, and trades in HexemBio's shares on secondary markets.